Rulin Zhuang

Dr. Rulin Zhuang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2019 in Obesity Reviews
Verified
Journal Article
Closed access
PDF file
RZRulin Zhuang
Rulin Zhuang
XGXinyu Ge
Xinyu Ge
LHLu Han
Lu Han
PYPing Yu
Ping Yu
XGXin Gong
Xin Gong
XZXiaohui Zhou
Xiaohui Zhou

1 January 2020 in Advances in Nutrition
Verified
Journal Article
Closed access
XGXinyu Ge
Xinyu Ge
LZLiang Zheng
Liang Zheng
RZRulin Zhuang
Rulin Zhuang
PYPing Yu
Ping Yu
ZXZhican Xu
Zhican Xu
HFHuimin Fan
Huimin Fan
The gut microbial metabolite trimethylamine N-oxide (TMAO) is increasingly regarded as a novel risk factor for cardiovascular events and mortality. However, little is known about the association between TMAO and hypertension. This meta-analysis was conducted to quantitatively assess the relation between the circulating TMAO concentration and hypertension prevalence. The PubMed, Cochrane Library, and Embase databases were systematically searched up to 17 June 2018. Studies recording the hypertension prevalence in members of a given population and their circulating TMAO concentrations were included. A total of 8 studies with 11,750 individuals and 6176 hypertensive cases were included in the analytic synthesis. Compared with low circulating TMAO concentrations, high TMAO concentrations were correlated with a higher prevalence of hypertension (RR: 1.12; 95% CI: 1.06, 1.17; P < 0.0001; I2 = 64%; P-heterogeneity = 0.007; random-effects model). Consistent results were obtained in all examined subgroups as well as in the sensitivity analysis. The RR for hypertension prevalence increased by 9% per 5-μmol/L increment (RR: 1.09; 95% CI: 1.05, 1.14; P < 0.0001) and 20% per 10-μmol/L increment of circulating TMAO concentration (RR: 1.20; 95% CI: 1.11, 1.30; P < 0.0001) according to the dose-response meta-analysis. To our knowledge, this is the first systematic review and meta-analysis demonstrating a significant positive dose-dependent association between circulating TMAO concentrations and hypertension risk.

8 September 2022 in Angiogenesis
Verified
Journal Article
Closed access
PDF file
MMMichael G. McCoy
Michael G. McCoy
AJAnurag Jamaiyar
Anurag Jamaiyar
GSGrasiele Sausen
Grasiele Sausen
HCHenry S. Cheng
Henry S. Cheng
DPDaniel Pérez-Cremades
Daniel Pérez-Cremades
Mark W. FeinbergMark W. Feinberg
Mark W. Feinberg

22 April 2024 in Apoptosis
Verified
Journal Article
Closed access
PDF file
JGJiayi Gu
Jiayi Gu
WHWei Huang
Wei Huang
ZDZheng Duanmu
Zheng Duanmu
RZRulin Zhuang
Rulin Zhuang
XYxilan yang
xilan yang

10 April 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
HCHenry S. Cheng
Henry S. Cheng
RZRulin Zhuang
Rulin Zhuang
DPDaniel Pérez-Cremades
Daniel Pérez-Cremades
JCJingshu Chen
Jingshu Chen
AJAnurag Jamaiyar
Anurag Jamaiyar
Mark W. FeinbergMark W. Feinberg
Mark W. Feinberg
Patients with peripheral artery disease (PAD) and diabetes have the highest risk of critical limb ischemia (CLI) and amputation, yet the underlying mechanisms remain incompletely understood. MicroRNA (miRNA) sequencing of plasma from diabetic patients with or without CLI was compared to diabetic mice with acute or subacute limb ischemia to identify conserved miRNAs. miRNA-KO mice on high-fat diet were generated to explore the impact on CLI. Comparison of dysregulated miRNAs from diabetic individuals with PAD and diabetic mice with limb ischemia revealed conserved miR-181 family members. High-fat–fed, diabetic Mir181a2b2 -KO mice had impaired revascularization in limbs due to abrogation of circulating Ly6C hi monocytes, with reduced accumulation in ischemic skeletal muscles. M2-like KO macrophages under diabetic conditions failed to produce proangiogenic cytokines. Single-cell transcriptomics of the bone marrow niche revealed that the reduced monocytosis in diabetic KO mice was a result of impaired hematopoiesis, with increased CXCR4 signaling in bone marrow Lineage – Sca1 + Kit + (LSK) cells. Exogenous Ly6C hi monocytes from nondiabetic KO mice rescued the impaired revascularization in ischemic limbs of diabetic KO mice. Increased Cxcr4 expression was mediated by the miR-181 target, Plac8 . Taken together, our results show that MiR-181a/b is a putative mediator of diabetic CLI and contributes to changes in hematopoiesis, monocytosis, and macrophage polarization.

22 May 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
HCHenry S. Cheng
Henry S. Cheng
DPDaniel Pérez-Cremades
Daniel Pérez-Cremades
RZRulin Zhuang
Rulin Zhuang
AJAnurag Jamaiyar
Anurag Jamaiyar
WWWinona Wu
Winona Wu
Mark W. FeinbergMark W. Feinberg
Mark W. Feinberg
Patients with peripheral artery disease (PAD) and diabetes compose a high-risk population for development of critical limb ischemia (CLI) and amputation, although the underlying mechanisms remain poorly understood. Comparison of dysregulated microRNAs from diabetic patients with PAD and diabetic mice with limb ischemia revealed the conserved microRNA, miR–130b-3p . In vitro angiogenic assays demonstrated that miR-130b rapidly promoted proliferation, migration, and sprouting in endothelial cells (ECs), whereas miR-130b inhibition exerted antiangiogenic effects. Local delivery of miR-130b mimics into ischemic muscles of diabetic mice ( db/db ) following femoral artery ligation (FAL) promoted revascularization by increasing angiogenesis and markedly improved limb necrosis and amputation. RNA-Seq and gene set enrichment analysis from miR-130b –overexpressing ECs revealed the BMP/TGF-β signaling pathway as one of the top dysregulated pathways. Accordingly, overlapping downregulated transcripts from RNA-Seq and miRNA prediction algorithms identified that miR-130b directly targeted and repressed the TGF-β superfamily member inhibin-β-A ( INHBA ). miR-130b overexpression or siRNA-mediated knockdown of INHBA induced IL-8 expression, a potent angiogenic chemokine. Lastly, ectopic delivery of silencer RNAs (siRNA) targeting Inhba in db/db ischemic muscles following FAL improved revascularization and limb necrosis, recapitulating the phenotype of miR-130b delivery. Taken together, a miR-130b / INHBA signaling axis may provide therapeutic targets for patients with PAD and diabetes at risk of developing CLI.